aTyr Pharma reported $59K in Interest Expense on Debt for its fiscal quarter ending in December of 2016.





Interest Expense On Debt Change Date
Ardelyx USD 5.8M 784K Sep/2025
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 480M 5M Sep/2025
Cipla INR 140.3M 8.5M Dec/2025
Compugen USD 954K 116K Sep/2025
CSL USD 104M 136M Jun/2025
Galapagos EUR 1.72M 940K Sep/2025
GlaxoSmithKline GBP 167M 17M Sep/2025
Grifols EUR 156.07M 31.46M Sep/2025
Novartis USD 281M 8M Sep/2025
Roche Holding CHF 304M 7.5M Jun/2025
United Therapeutics USD 3M 4.3M Sep/2025